Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 13
Review
Clinical Utility of CYP2C19 Genotype-Guided Antiplatelet Therapy in Patients at Risk of Adverse Cardiovascular and Cerebrovascular Events: A Review of Emerging Evidence
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,889 | Dovepress* | 5,616+ | 991 | 6,607 | |
| PubMed Central* | 2,273 | 532 | 2,805 | ||
| Totals | 7,889 | 1,523 | 9,412 | ||
| *Since 27 July 2020 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar